Mark For: NOVOBIO™ trademark registration is intended to cover the categories of house mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith. [all]
Status
2020-10-06 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED 2019-11-13
Basis
1(b)
Class Status
ACTIVE
Primary US Classes
006:
Chemicals and Chemical Compositions
018:
Medicines and Pharmaceutical Preparations
044:
Dental, Medical and Surgical Appliances
046:
Foods and Ingredients of Foods
051:
Cosmetics and Toilet Preparations
052:
Detergents and Soaps
Primary International Class
005 - Primary Class
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Law Office Assigned
M60
Employee Name
NASSERGHODSI, SAHAR
Timeline
2019-02-06
Application Filed
2019-10-24
Abandon
2019-11-13
Location: TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
2019-11-13
Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi
NIAZI, SARFARAZ 20 RIVERSIDE DRIVE DEERFIELD, IL 60015
Good, Services, and Codes
(ABANDONED) IC 005. US 006 018 044 046 051 052. G & S: House mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
House mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
Trademark Filing History
Description
Date
Proceeding Number
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
2019-11-13
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2019-11-13
NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-04-23
6325
NON-FINAL ACTION WRITTEN
2019-04-23
93665
NON-FINAL ACTION E-MAILED
2019-04-23
6325
ASSIGNED TO EXAMINER
2019-04-18
93665
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
Niazi, Sarfaraz
Drawing
TEAS RF New Application
| 